Sign in

CIK 0002002988 · <br>Emerging growth company

Retension Pharmaceuticals, Inc.

Sign in to watch
Ticker
RTSN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
other
EIN
932592788
Phone
(703) 624-2024
Business address
C/O REDUX THERAPEUTICS, LLC, 902 TURKEY RUN ROAD, MCLEAN, VA, 22101
  1. 4 Derivatives Options or other derivatives
  2. 3 Insider Initial Statement of Ownership
  3. 8-K Event Executive or director change
  4. 4 Derivatives Options or other derivatives
  5. 3 Insider Initial Statement of Ownership
  6. SCHEDULE 13G Stake Statement of Beneficial Ownership
  7. SCHEDULE 13G Stake Statement of Beneficial Ownership
  8. SCHEDULE 13G Stake Statement of Beneficial Ownership
  9. SCHEDULE 13D Stake Beneficial Ownership Report
  10. S-8 Other Securities Offered to Employees in Benefit Plans
  11. 4 Open-market buy CHIEF EXECUTIVE OFFICER bought 20,800 shares at $12.00 ($249,600)
  12. 4 Conversion CHIEF SCIENTIFIC OFFICER acquired 6,666 shares (conversion)
  13. 4 Conversion Director acquired 5,637 shares (conversion)
  14. 4 Derivatives Options or other derivatives
  15. 4 Conversion CHIEF OPERATING OFFICER acquired 4,115 shares (conversion)
  16. 4 Open-market buy Director bought 10,000 shares at $12.00 ($120,000)
  17. 4 Conversion Director acquired 6,666 shares (conversion)
  18. 3 Insider Initial Statement of Ownership
  19. 8-K Event Bylaws or fiscal year change
  20. 424B4 Offering Prospectus

Page 1 of 3 · 45 filings